CD274 and neoplasm: Immune checkpoint molecules, such as programmed cell death protein 1 (PD-1), its ligand PD-L1, and protein 4 associated with cytotoxic T lymphocytes (CTLA-4), attenuate T cell activation in cancer and thereby induce tumor immunotolerance [13].